Blood Processing Devices and Consumables MarketSize and Trends
Global blood processing devices and consumables market is estimated to be valued at US$ 45.7 Bn in 2023, and is expected to exhibit a CAGR of 6.7% during the forecast period (2023-2030).
Figure 1. Global Blood Processing Devices and Consumables Market Share (%), By Product Type, 2023
Global Blood Processing Devices and Consumables Market– Drivers
- Increasing research and development in the field of life sciences: Increasing key developments and growing research in the field of life sciences to carry out the processing of blood efficiently and effectively is expected to boost the global blood processing devices and consumables market growth. For instance, in June 2021, according to Kings College London, neuro-degenerative diseases such as down syndrome can be diagnosed by the levels of protein present in blood called neurofilament light chain. Thus, research and development in blood screening that requires blood processing is expected to drive the global blood processing devices and consumables market growth.
- Increasing government initiatives for blood and plasma donations: Increasing government initiatives for the blood and plasma donations is expected to boost demand for blood processing devices and consumables for the storage of blood and plasma. For instance, in August 2022, U.S. Department of Health and Human Services (HHS) launched a campaign named Giving = Living to increase blood and plasma donations in the U.S. The campaign aimed at increasing awareness about importance of donating blood and plasma, and to encourage the U.S. population to develop new and regular donation habits.
Figure 2. Global Blood Processing Devices and Consumables Market Share(%), By Region, 2023
Global Blood Processing Devices and Consumables Market: Trends
- Launch of ultra-low temperature controlled logistics service: Global blood processing devices and consumables market is increasingly influenced by the pivotal trend of launching ultra-low temperature controlled logistic services for the pharmaceutical industry. This development addresses the critical need for the safe and reliable transportation of the blood products. For instance, in June 2022, Nippon Express Co., Ltd., a logistic company, launched a logistics service capable of handling goods that requires ultra-low temperatures (-20°C to -85°C) for the pharmaceutical industry. As a result, pharmaceutical goods such as blood products can be transported and stored at extremely low temperatures while still in the research and development phase as well as during the formulation process. As a result, Nippon Express provides temperature-controlled shipping services for a variety of pharmaceutical products including raw materials, intermediates, active pharmaceutical ingredients, and finished goods.